Lee CL, Kuo HC. Intravescial botulinum toxin A injections do not benefit patients with ulcer type interstitial cystitis. Pain Physician 2013; 16: 109-16
Lee CL, Jiang YH, Kuo HC: Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls. BJU Int. 2013 Dec;112(8):1156-62
Lee CL, Su BC, Kuo HC. The dreadful and the deadly erection-Malignant priapism from renal cell carcinoma. Urol Sci 2014; 25:152-4.
Lee CL, Peng CH, Kuo HC. Therapeutic effects and predictive factors for successful intravesical hyaluronic acid instillation on interstitial cystitis/bladder pain syndrome. Urol Sci2015; 26:125-30.
Lee CL, Kuo HC. Long-term efficacy and safety of repeated intravescial onabotulinumtoxinA injections plus hydrodistention in the treatment of interstitial cystitis/ bladder pain syndrome. Toxins 2015; 7:4283-93.
Lee CL, Kuo HC. Videourodynamic analysis in men with lower urinary tract symptoms: correlation between age and prostate size with lower urinary tract dysfunction. Urol Sci 2016; 27:21-5.
Lee CL, Kuo HC. Botulinum toxin A treatment for lower urinary tract symptoms/ benign prostatic hyperplasia. Urol Sci 2017; 28:119-22.
Lee CL, Kuo HC. Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia. Tzu Chi Med J 2017; 29:6-11. (Review)
Lee CL, Kuo HC. Pathophysiology of benign prostate enlargement and lower urinary tract symptoms – current concept. Tzu Chi Med J 2017; 29:79-83. (Review)
Lee CL, Kuo HC. Tailoring medication for lower urinary tract symptoms in men based on International Prostate Symptom Score voiding to storage ratio. Urology 2018; 120:30-35.
Lee CL, Kuo HC. Efficacy and safety of mirabegron, a β-3 adrenoceptor agonist, in patients with detrusor hyperactivity and impaired contractility. Low Urin Tract Symptoms 2019; 11:O93-7.
Lee CL, Kuo HC. Male patients with higher nocturnal urinary frequency episodes are more likely to benefit from alpha-blocker therapy for bothersome nocturia. Low Urin Tract Symptoms 2019; 11:O174-9.
Lee CL, Ong HL, Kuo HC. Therapeutic efficacy of mirabegron 25 mg monotherapy in patients with nocturia-predominant hypersensitive. Tzu Chi Med J 2020; 32:30-5.
Lee CL, Kuo HC. Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose? Tzu Chi Med J 2023; 35:312-316.
